SU3327

CAS No. 40045-50-9

SU3327( —— )

Catalog No. M24361 CAS No. 40045-50-9

SU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 53 In Stock
10MG 87 In Stock
25MG 165 In Stock
50MG 295 In Stock
100MG 447 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SU3327
  • Note
    Research use only, not for human use.
  • Brief Description
    SU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
  • Description
    SU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
  • In Vitro
    ——
  • In Vivo
    Animal Model:Male BKS.Cg-+Leprdb/+Leprdb/OlaHsd db/db mice (11-week-old ) injected with insulin Dosage:25 mg/kg Administration:Intraperitoneal injection Result:Resulted in a statistically significant reduction in blood glucose levels.
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    JNK
  • Recptor
    JNK|JNK-JIP interactions
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    40045-50-9
  • Formula Weight
    261.3
  • Molecular Formula
    C5H3N5O2S3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:62.5 mg/mL (239.19 mM; Need ultrasonic)
  • SMILES
    Nc1nnc(Sc2ncc([N+]([O-])=O)s2)s1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.De SK, et al. Design, synthesis, and structure-activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal kinase. J Med Chem. 2009 Apr 9;52(7):1943-52.
molnova catalog
related products
  • [D-Arg1,D-Phe5,D-Trp...

    Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin receptor signaling. Also antagonist at tachykinin, bradykinin, CCK and bombesin receptors. Induces apoptosis and inhibits cancer cell growth in vitro.

  • SP600125

    SP600125 is a potent, selective, reversible, ATP-competitive inhibitor of JNK with IC50 of 40, 40 and 90 nM for JNK1, JNK2 and JNK3, respectively.

  • d-Epigalbacin

    d-Epigalbacin is a naturally occurring lignin. d-Epigalbacin is a potent, selective JNKs inhibitor, with IC50s of 1.7 μM, 2.9 μM and 1.74 μM for JNK1, JNK2 and JNK3, respectively.